CVS Health to Split Into Two Independent Companies by 2028
CVS Health reported Q3 adjusted EPS of $2.09, topping estimates, and raised full-year guidance to at least $8.20 as it plans to split into two companies by 2028.
CVS Health reported Q3 adjusted EPS of $2.09, topping estimates, and raised full-year guidance to at least $8.20 as it plans to split into two companies by 2028.
Humana rose after its main plan regained 4 stars; Alignment fell as its biggest plan dropped to 3.5.
BofA kept Buy ratings, calling the news a clearing event.
CVS Health reports strong Q2 results with $2.58 adjusted EPS and raises 2026 guidance, but shares fall on a muted 2027 outlook and cautious cost warnings.
CVS had strong Q1: revenue $100.4B, earnings beat expectations, raised outlook, cash flow up. Stock rose.
CMS boosts 2027 Medicare payments 2.5%, giving insurers $13B+, keeping plans stable and seniors’ benefits solid. Stocks jump.